Developing predictive in vitro models and testing services to accelerate clinical translation and drug discovery
Find out more Play VideoPredictive and functional in vitro tissue models
are the foundation of our assay services
Retina Models
Retinal organoid and pigmented epithelium models for use in modelling of retinopathies, safety studies and therapeutic vector efficacy and safety assessment
Find out more
Kidney Nephron Models
We run toxicity, DDI, transporter assay and cross species comparison studies on our models of the proximal tubule to give you the ability to measure how your drug affects the kidney
Find out more
Lung Airway Models
A suite of airway models that enable drug candidate screening and study of fibrotic disease mechanism, mucociliary clearance and compound efficacy
Find out moreWho we are
We are a team of globally recognised experts in building and applying complex models of human tissues for drug discovery.
We are cell biologists, tissue physiologists, bioegineers and assay development scientists focused on building models that balance complexity, functionality, throughput and efficiency to improve the predictive power of in vitro data.
Find out moreWhat we do
We carry out bespoke efficacy, safety, disease modelling and membrane transporter kinetics studies on our models and provide products that enable customers to generate data to de-risk drug discovery and development.
Our experts collaborate with customers to design studies to provide data that answer their critical questions in pre-clinical drug development. We run the study and provide you with data interpretation or we can supply products for you to run in-house studies.
Find out moreOur Commitment
To improve the success of in vitro to clinical trials translation by developing and validating in vitro models for biomedical research.
We aim to contribute to the development of new innovative therapies by delivering services, products and tools based on our models of human tissues that provide data that informs and predicts how these therapies will behave in humans. Through the wider adoption of this approach, our work will advance the 3R’s policy in drug development.
Find out moreHow we innovate to support drug discovery
-
Build human cell-based in vitro models
-
Apply our in-depth expertise to design the right study
-
Provide the data that answers key efficacy, safety or transport questions
-
Provide the tool or assay for customer in-house studies
-
Timely delivery of data to fit with customers deadlines
Newcells mission is to de-risk the decision-making process in drug development by providing physiologically relevant in vitro models that most accurately predict in vivo outcomes.
Globally recognised scientific expertise in cell physiology and organoid technology is embedded in all products & services. We engineer in vitro models from primary tissues and iPSCs to accelerate drug discovery and improve clinical translation.
About us
Innovative company based in the heart of Newcastle upon Tyne, UK
Latest updates
How is AI Impacting drug discovery?
How do you envision the role of AI evolving in the drug discovery process over the next decade? Colin Brown: “The role of AI in the discovery…
Read update
Transforming Drug Development with 3D Retina Models
Newcells Biotech Limited, a team of internationally recognised experts in the building and application of complex models of human tissues for drug discovery, was awarded £1m to deliver their…
Read update
Follow us on social media:
